Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interests of Rui Qin, Ph.D., focus on statistical design and analysis of clinical trials in cancer, specifically the development of Bayesian and adaptive designs for early-phase clinical trials and joint models for analysis of complex data from cancer control clinical trials.
Dr. Qin's goal is to implement novel designs and perform rigorous analysis of clinical trials through collaboration with clinical investigators.
Novel dose-finding designs for early phase I clinical trials may correctly identify biologically optimal doses for further testing. Bayesian designs for phase II clinical trials may incorporate historical information and facilitate flexible monitoring and decision making. Joint models to analyze clinical trial data may provide additional findings and accurate interpretation.
Each research project improves the efficiency of clinical trials to evaluate new therapies for cancer.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.